References
- FroehlichTELanphearBPEpsteinJNBarbaresiWJKatusicSKKahnRSPrevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US childrenArch Pediatr Adolesc Med2007161985786417768285
- Centers for Disease Control and Prevention (CDC)Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children – United States, 2003 and 2007MMWR Morb Mortal Wkly Rep201059441439144321063274
- LaraCFayyadJde GraafRChildhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey InitiativeBiol Psychiatry2009651465419006789
- SchubinerHKatragaddaSOverview of epidemiology, clinical features, genetics, neurobiology, and prognosis of adolescent attention-deficit/hyperactivity disorderAdolesc Med State Art Rev2008192209215 vii18822827
- KesslerRCAdlerLBarkleyRThe prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey ReplicationAm J Psychiatry2006163471672316585449
- BiedermanJMickEFaraoneSVAge-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom typeAm J Psychiatry2000157581681810784477
- HartELLaheyBBLoeberRApplegateBFrickPJDevelopmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal studyJ Abnorm Child Psychol19952367297498609310
- ToddRDHuangHTodorovAAPredictors of stability of attention-deficit/hyperactivity disorder subtypes from childhood to young adulthoodJ Am Acad Child Adolesc Psychiatry2008471768518174828
- AdlerLASpencerTJBiedermanJThe internal consistency and validity of the attention-deficit/hyperactivity disorder rating scale (ADHD-RS) with adult ADHD prompts as assessed during a clinical treatment trialJ ADHD Relate Disord2009111424
- MillsteinRBWilensTEBiedermanJSpencerTJPresenting ADHD symptoms and subtypes in clinically referred adults with ADHDJ Atten Disord199723159166
- American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, Fourth Edition. Text RevisionArlington, VAAmerican Psychiatric Association2000
- KesslerRCGreenJGAdlerLAStructure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic ScaleArch Gen Psychiatry201067111168117821041618
- WeissMDWeissJRA guide to the treatment of adults with ADHDJ Clin Psychiatry200465Suppl 3273715046533
- WilensTEDodsonWA clinical perspective of attention-deficit/hyperactivity disorder into adulthoodJ Clin Psychiatry200465101301131315491232
- HerveyASEpsteinJNCurryJFNeuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic reviewNeuropsychology200418348550315291727
- EpsteinJNJohnsonDEVariaIMConnersCKNeuropsychological assessment of response inhibition in adults with ADHDJ Clin Exp Neuropsychol200123336237111404813
- Malloy-DinizLFuentesDLeiteWBCorreaHBecharaAImpulsive behavior in adults with attention deficit/hyperactivity disorder: characterization of attentional, motor and cognitive impulsivenessJ Int Neuropsychol Soc200713469369817521490
- GibbinsCWeissMClinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adultsCurr Psychiatry Rep20079542042617915083
- American Academy of Pediatrics Committee on Quality Improvement and Subcommittee on Attention-Deficit/Hyperactivity DisorderClinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorderPediatrics200010551158117010836893
- WolraichMLHannahJNPinnockTYBaumgaertelABrownJComparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sampleJ Am Acad Child Adolesc Psychiatry19963533193248714320
- BarbaresiWJKatusicSKColliganRCWeaverALLeibsonCLJacobsenSJLong-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based studyJ Dev Behav Pediatr200627111016511362
- RobisonRJReimherrFWMarchantBKFaraoneSVAdlerLAWestSAGender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysisJ Clin Psychiatry200869221322118211131
- SobanskiEBrüggemannDAlmBSubtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustmentEur Psychiatry200823214214918024089
- ZuckerMMorrisMKIngramSMMorrisRDBakemanRConcordance of self- and informant ratings of adults’ current and childhood attention-deficit/hyperactivity disorder symptomsPsychol Assess200214437938912501563
- PliszkaSAACAP Work Group on Quality IssuesPractice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry200746789492117581453
- GreenhillLLPliszkaSDulcanMKAmerican Academy of Child and Adolescent PsychiatryPractice parameter for the use of stimulant medications in the treatment of children, adolescents, and adultsJ Am Acad Child Adolesc Psychiatry200241Suppl 226S49S11833633
- FaraoneSVBuitelaarJComparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysisEur Child Adolesc Psychiatry201019435336419763664
- FaraoneSVGlattSJA comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizesJ Clin Psychiatry201071675476320051220
- Vyvanse® (lisdexamfetamine dimesylate) [package insert]Wayne, PAShire US Inc2012
- BiedermanJKrishnanSZhangYMcGoughJJFindlingRLEfficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group studyClin Ther200729345046317577466
- AdlerLAGoodmanDWKollinsSH303 Study GroupDouble-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderJ Clin Psychiatry20086991364137319012818
- FindlingRLGinsbergLDJainRGaoJEffectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: an open-label, dose-optimization studyJ Child Adolesc Psychopharmacol200919664966220035583
- FindlingRLChildressACKrishnanSMcGoughJJLong-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderCNS Spectr200813761462018622366
- WeislerRYoungJMattinglyGGaoJSquiresLAdlerL304 Study GroupLong-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderCNS Spectr2009141057358520095369
- BiedermanJBoellnerSWChildressALopezFAKrishnanSZhangYLisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom studyBiol Psychiatry200762997097617631866
- WigalSBKollinsSHChildressACSquiresL311 Study GroupA 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderChild Adolesc Psychiatry Ment Health2009311719508731
- WigalTBramsMGasiorMGaoJSquiresLGiblinJ316 Study GroupRandomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment designBehav Brain Funct201063420576091
- DuPaulGJPowerTJAnastopoulosADReidRADHD Rating Scale-IV: Checklists, Norms, and Clinical InterpretationNew York, NYGuilford Press1998
- WigalSBKollinsSHChildressACAdeyiBEfficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the dayChild Adolesc Psychiatry Ment Health201043221156071
- LagakosSWThe challenge of subgroup analyses – reporting without distortingN Engl J Med2006354161667166916625007
- WangRLagakosSWWareJHHunterDJDrazenJMStatistics in medicine – reporting of subgroup analyses in clinical trialsN Engl J Med2007357212189219418032770